©2024 Stanford Medicine
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Not Recruiting
Trial ID: NCT01556828
Purpose
The goal of this study is to identify genetic changes associated with the initiation,
progression, and treatment response of response of cutaneous and hematologic disorders using
recently developed high-throughput sequencing technologies. The improved understanding of the
genetic changes associated with cutaneous and hematologic disorders may lead to improved
diagnostic, prognostic and therapeutic options for these disorders.
Official Title
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Stanford Investigator(s)
Paul A. Khavari, MD, PhD
Carl J. Herzog Professor of Dermatology in the School of Medicine
Carolyn Lee MD PhD
Assistant Professor of Dermatology
Sumaira Z. Aasi, MD
Clinical Professor, Dermatology
Susan M. Swetter, MD
Professor of Dermatology
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Eligibility
Inclusion Criteria:
- 18 years of age or older
- Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic
disorder being examined.
- Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.
Exclusion Criteria:
- Less than 18 years of age
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305